Senior Associate Scientist – In Vivo Pharmacology
Company | Bristol Myers Squibb |
---|---|
Location | Cambridge, MA, USA |
Salary | $Not Provided – $Not Provided |
Type | Full-Time |
Degrees | Bachelor’s, Master’s |
Experience Level | Mid Level, Senior |
Requirements
- Bachelor’s Degree + 4+ years of academic and / or industry experience
- Master’s Degree + 2+ years of academic and / or industry experience
Responsibilities
- Implement studies designed to evaluate novel BBB delivery technologies and therapeutic modalities applied to diseases of strategic interest to the Neuroscience TRC
- Maintain and integrate transgenic and other animal models to evaluate and select drug candidates for further investment
- Support programs employing novel delivery technologies for neurodegenerative and neuromuscular disorders
Preferred Qualifications
- BA, BS or MS with 4+ years of experience in drug discovery research spanning small molecule, biotherapeutics and genetic medicines discovery, with an emphasis on the evaluation of novel delivery technologies and approaches to enhance CNS delivery of therapeutic agents, using genetically modified animals where appropriate
- Hands on experience in in vivo pharmacology, including small animal handling, surgical techniques, maintenance and breeding of transgenic animal colonies, coordination of research activities and coordination of research activities with external partners and vendors
- Experience working as part of an interdisciplinary drug discovery team.
- Experience creating and applying genetically engineered animal models of neurologic disease towards identification of novel therapeutics
- Experience leading drug discovery programs from ideation to delivery of a therapeutic candidate
- Expertise in blood-brain-barrier delivery technologies spanning bi-specific antibodies and genetic medicines
- Experience contributing to external collaborations and partnerships
- Excellent oral and written communication skills
- Ability to work both independently and as an integrated member of multidisciplinary drug development teams